Transcranial Galvanic Stimulation After Stroke
Launched by CHARITE UNIVERSITY, BERLIN, GERMANY · Dec 1, 2006
Trial Information
Current as of June 02, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • subacute stroke
- • stroke interval 3 to 8 weeks
- • severe upper limb paresis
- • Fugl-Meyer \< 18
- Exclusion Criteria:
- • history of epilepsy
- • antiepileptic, neuroleptic medication
- • metal implants
About Charite University, Berlin, Germany
Charité - Universitätsmedizin Berlin is a leading academic medical center in Germany, renowned for its commitment to excellence in research, education, and patient care. As one of Europe's largest university hospitals, Charité integrates cutting-edge clinical practices with innovative research initiatives, fostering interdisciplinary collaboration across various medical fields. The institution is dedicated to advancing healthcare through rigorous clinical trials, contributing to the development of new therapies and treatment protocols. With a strong emphasis on translational medicine, Charité aims to bridge the gap between scientific discovery and practical application, ultimately enhancing patient outcomes and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Berlin, , Germany
Kreischa, , Germany
Bozen, , Italy
Patients applied
Trial Officials
Stefan Hesse, MD
Principal Investigator
Charité -University Medicine Berlin; Medical Park Berlin
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials